Anchen Pharmaceuticals’ products
Desvenlafaxine extended-release tablets (75 mg)
Indication: Depression—mid-range strength, extended-release dosage
Desvenlafaxine extended-release tablets (150 mg)
Indication: Depression—higher strength for once-daily extended-release administration
Venlafaxine hydrochloride extended-release capsules (37.5 mg base equivalent)
Indication: Depression—low-dose extended-release formulation
Venlafaxine hydrochloride extended-release capsules (75 mg base equivalent)
Indication: Depression—moderate-dose extended-release formulation
Venlafaxine hydrochloride extended-release capsules (150 mg base equivalent)
Indication: Depression—higher-dose extended-release formulation
No comments:
Post a Comment